|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang L: Incidence and mortality of gastric
cancer in China. World J Gastroenterol. 12:17–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen WQ, Zheng RS, Zhang SW, Zeng HM and
Zou XN: The incidences and mortalities of major cancers in China,
2010. Chin J Cancer. 33:402–405. 2014.PubMed/NCBI
|
|
4
|
Washington K: 7th edition of the AJCC
cancer staging manual: Stomach. Ann Surg Oncol. 17:3077–3079. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thrumurthy SG, Chaudry MA, Hochhauser D
and Mughal M: The diagnosis and management of gastric cancer. BMJ.
347:f63672013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stadtländer CT and Waterbor JW: Molecular
epidemiology, pathogenesis and prevention of gastric cancer.
Carcinogenesis. 20:2195–2208. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Figueiredo C, Garcia-Gonzalez MA and
Machado JC: Molecular pathogenesis of gastric cancer. Helicobacter.
18 Suppl 1:S28–S33. 2013. View Article : Google Scholar
|
|
8
|
Kapp LN, Painter RB, Yu LC, van Loon N,
Richard CW III, James MR, Cox DR and Murnane JP: Cloning of a
candidate gene for ataxia-telangiectasia group D. Am J Hum Genet.
51:45–54. 1992.PubMed/NCBI
|
|
9
|
Reymond A, Meroni G, Fantozzi A, Merla G,
Cairo S, Luzi L, Riganelli D, Zanaria E, Messali S, Cainarca S, et
al: The tripartite motif family identifies cell compartments. EMBO
J. 20:2140–2151. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hatakeyama S: Early evidence for the role
of TRIM29 in multiple cancer models. Expert Opin Ther Targets.
20:767–770. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–428. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kanno Y, Watanabe M, Kimura T, Nonomura K,
Tanaka S and Hatakeyama S: TRIM29 as a novel prostate basal cell
marker for diagnosis of prostate cancer. Acta Histochem.
116:708–712. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun H, Dai X and Han B: TRIM29 as a novel
biomarker in pancreatic adenocarcinoma. Dis Markers.
2014:3178172014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou ZY, Yang GY, Zhou J and Yu MH:
Significance of TRIM29 and β-catenin expression in non-small-cell
lung cancer. J Chin Med Assoc. 75:269–274. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fristrup N, Birkenkamp-Demtröder K,
Reinert T, Sanchez-Carbayo M, Segersten U, Malmström PU, Palou J,
Alvarez-Múgica M, Pan CC, Ulhøi BP, et al: Multicenter validation
of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers
in non-muscle-invasive bladder cancer. Am J Pathol. 182:339–349.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lai W, Zheng X, Huang Q, Wu X and Yang M:
Down-regulating ATDC inhibits the proliferation of esophageal
carcinoma cells. Eur Rev Med Pharmacol Sci. 18:3511–3516.
2014.PubMed/NCBI
|
|
17
|
Kosaka Y, Inoue H, Ohmachi T, Yokoe T,
Matsumoto T, Mimori K, Tanaka F, Watanabe M and Mori M: Tripartite
motif-containing 29 (TRIM29) is a novel marker for lymph node
metastasis in gastric cancer. Ann Surg Oncol. 14:2543–2549. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang L, Heidt DG, Lee CJ, Yang H, Logsdon
CD, Zhang L, Fearon ER, Ljungman M and Simeone DM: Oncogenic
function of ATDC in pancreatic cancer through Wnt pathway
activation and beta-catenin stabilization. Cancer Cell. 15:207–219.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ernst T, Hergenhahn M, Kenzelmann M, Cohen
CD, Bonrouhi M, Weninger A, Klären R, Gröne EF, Wiesel M, Güdemann
C, et al: Decrease and gain of gene expression are equally
discriminatory markers for prostate carcinoma: A gene expression
analysis on total and microdissected prostate tissue. Am J Pathol.
160:2169–2180. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nacht M, Ferguson AT, Zhang W, Petroziello
JM, Cook BP, Gao YH, Maguire S, Riley D, Coppola G, Landes GM, et
al: Combining serial analysis of gene expression and array
technologies to identify genes differentially expressed in breast
cancer. Cancer Res. 59:5464–5470. 1999.PubMed/NCBI
|
|
21
|
Hosoi Y, Kapp LN, Murnane JP, Matsumoto Y,
Enomoto A, Ono T and Miyagawa K: Suppression of
anchorage-independent growth by expression of the
ataxia-telangiectasia group D complementing gene, ATDC. Biochem
Biophys Res Commun. 348:728–734. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou XM, Sun R, Luo DH, Sun J, Zhang MY,
Wang MH, Yang Y, Wang HY and Mai SJ: Upregulated TRIM29 promotes
proliferation and metastasis of nasopharyngeal carcinoma via
PTEN/AKT/mTOR signal pathway. Oncotarget. 7:13634–13650.
2016.PubMed/NCBI
|
|
23
|
Qiu F, Xiong JP, Deng J and Xiang XJ:
TRIM29 functions as an oncogene in gastric cancer and is regulated
by miR-185. Int J Clin Exp Pathol. 8:5053–5061. 2015.PubMed/NCBI
|
